[1]张宗久胡豫AxelHofmann刘远立纪宏文.促进实施患者血液管理的专家倡议[J].中国卫生质量管理,2022,29(09):081-86.[doi:10.13912/j.cnki.chqm.2022.29.9.18 ]
　ZHANG Zongjiu,HU Yu,AXEL Hofmann.Expert Initiatives to Promote the Implementation of Patient Blood Management[J].Chinese Health Quality Management,2022,29(09):081-86.[doi:10.13912/j.cnki.chqm.2022.29.9.18 ]
点击复制

促进实施患者血液管理的专家倡议
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第29卷
期数:
2022年09期
页码:
081-86
栏目:
血液安全
出版日期:
2022-09-28

文章信息/Info

Title:
Expert Initiatives to Promote the Implementation of Patient Blood Management
作者:
张宗久胡豫AxelHofmann刘远立纪宏文
清华大学医院管理研究院
Author(s):
ZHANG Zongjiu; HU Yu; AXEL Hofmann
Institute of Hospital Management，Tsinghua University
关键词:
患者血液管理; 贫血; 失血; 凝血障碍; 出血性疾病; 输血; 多学科协作
Keywords:
Patient Blood Management; Anemia; Blood Loss; Coagulopathy; Bleeding Disorder; Blood Transfusion; Multidisciplinary Collaboration
分类号:
R197.323；R331.1
DOI:
10.13912/j.cnki.chqm.2022.29.9.18
文献标志码:
A
摘要:
贫血、失血以及凝血障碍每年影响数十亿人，均是患者不良结局（死亡率和发病率等）的独立风险因素。患者血液管理是一种全新的医疗模式，可显著减轻或避免此类风险。 本研究基于患者血液管理的多重获益和我国相关政策背景发起专家倡议，以促进医疗机构有效实施患者血液管理。专家们一致认为患者血液管理需要卫生健康主管部门的政策推动，相关教育培训和科学研究的促进，医疗机构全员的积极参与，并辅以创新的诊疗路径、合理的医保支付报销方案以及基于数据的评价手段等。
Abstract:
Anemia, blood loss and coagulopathy with bleeding are affecting billions of individuals every year. Each of these conditions represents an independent risk factor for adverse patient outcomes including mortality and morbidity. Patient blood management is a new medical paradigm that can significantly reduce or avoid such risks.Based on the multiple benefit results of patient blood management and relevant policy background in China, this expert initiative was launched to facilitate the implementation of patient blood management for medical institutions. It is believed that this model requires the policy promotion of the competent health authorities, the implementation of education and training, the active participation of all medical institutions and supplementation by innovative diagnosis and treatment paths, reasonable reimbursement plans of medical insurance and evaluation tools based on data.

参考文献/References:

［1］World Health Organization.The urgent need to implement patient blood management：policy brief［EB/OL］. （2021）［2022-07-25］.https://apps.who.int/iris/handle/10665/346655. ［2］SHANDER A，HARDY JF，OZAWA S，et al. A global definition of patient blood management［J］. Anesthesia and Analgesia，2022,135(3):476-488. ［3］MICHAEL FL，AXEI H，SIMON T，et al.Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals［J］.Transfusion，2017，57（6）：1347-1358. ［4］纪宏文，李志远，孙寒松，等. 多学科血液管理对心脏瓣膜手术患者输血和转归的影响［J］.中华医学杂志，2014，94（7）：488-490. ［5］国家卫生健康委员会.围手术期患者血液管理指南：WS/T 796-2022［S］.2022. ［6］KRISHNASIVAM D，TRENTINO KM，BURROWS S，et al.Anemia in hospitalized patients: an overlooked risk in medical care［J］.Transfusion，2018，58（11）：2522-2528. ［7］World Health Organization.The global prevalence of anaemia in 2011［EB/OL］. （2015）［2022-07-25］.https://apps.who.int/iris/handle/10665/177094. ［8］COTTER J，BALDAIA C，FERREIRA M，et al. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding：a systematic review［J］. World J Gastroenterol，2020，26（45）：7242-7257. ［9］张金磊，李路平.中国居民2008年缺铁性贫血疾病负担分析［J］.中国公共卫生，2011，27（5）：647. ［10］凌寒.我国缺铁性贫血已造成显著疾病负担：复旦大学发布中国缺铁性贫血疾病负担和诊疗现状研究成果［J］.中国当代医药，2012，19（32）：1. ［11］CARROLI G，CUESTA C，ABALOS E，et al.Epidemiology of postpartum haemorrhage：a systematic review［J］.Best Pract Res Clin Obstet Gynaecol，2008，22（6）：999-1012. ［12］GMEZ-RAMIREZ S，JERICC，MUOZ M.Perioperative anemia: prevalence，consequences and pathophysiology［J］.Transfus Apher Sci，2019，58(4)：369-374. ［13］ROSE J，WEISER TG，HIDER P，et al.Estimated need for surgeryworldwide based on prevalence of diseases：a modelling strategy for the WHO Global Health Estimate［J］.Lancet Glob Health，2015，3（Suppl 2）：S13-S20. ［14］RANUCCI M，BARYSHNIKOVA E，CASTELVECCHIO S，et al.Major bleeding, transfusions, and anemia：the deadly triad of cardiac surgery［J］.Ann Thorac Surg，2013，96(2)：478-485. ［15］STOKES ME，YE X，SHAH M，et al.Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients［J］.BMC Health Serv Res，2011，11：135. ［16］ALSTRM U，LEVIN L，STHLE E，et al.Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery［J］.Br J Anaesth，2012，108(2)：216-222. ［17］PATEL SV, KIDANE B, KLINGEL M, et al. Risks associated with red blood cell transfusion in the trauma population, a meta-analysis［J］.Injury，2014，45(10)：1522-1533. ［18］National Blood Authority (Australia).Patient Blood Management Guidelines: Module 1 Critical Bleeding/Massive Transfusion［EB/OL］. （2011）［2022-07-27］.https://www.blood.gov.au/pbm-module-1. ［19］GOMBOTZ H，REHAK PH，SHANDER A，et al. Blood use in elective surgery: the Austrian benchmark study［J］.Transfusion，2007，47（8）：1468-1480. ［20］SPAHN DR，MOCH H，HOFMANN A，et al. Patient blood management: the pragmatic solution for the problems with blood transfusions［J］.Anesthesiology，2008，109（6）：951-953. ［21］Assembly World Health Sixty-Third.Vailability, safety and quality of blood products［EB/OL］. （2010-05-21）［2022-07-25］.http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf. ［22］HOFMANN A，FARMER S，SHANDER A.Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management［J］.The Oncologist，2011，16（Suppl 3）：3-11. ［23］World Health Organization.WHO action framework to advance universal access to safe, effective and quality assured blood products 2020-2023［EB/OL］. （2020-02-19）［2022-07-25］.https://www.who.int/news-room/detail/19-02-2020-who-action-framework-to-advance-universal-access-to-safe-effective-and-quality-assured-blood-products-2020--2023. ［24］AAPRO M，BEGUIN Y，BOKEMEYER C，et al.Management of anaemia and iron deficiency in patients with cancer：ESMO Clinical Practice Guidelines［J］.Ann Oncol，2018，29（Suppl 4）：iv271. ［25］HOFMANN A，AAPRO M，FEDOROVA T，et al.Patient blood management in oncology in the Russian Federation：resolution to improve oncology care［J］.Journal of Modern Oncology，2020，22（3）：59-78. ［26］MINCK S，ROBINSON K，SAXON B，et al.Patient blood management:the GP's guide［J］.Aust Fam Physician，2013，42（5）：291-297. ［27］PASRICHA SR，TYE-DIN J，MUCKENTHALER MU，et al.Iron deficiency［J］.Lancet，2021，397（1270）：233-248. ［28］World Health Organization.Aneamia［EB/OL］. ［2022-07-25］.https://www.who.int/health-topics/anaemia#tab=tab_1. ［29］LEAHY MF，HOFMANN A，TOWLER S，et al.Improved outcomes and reduced costs associated with a health-system-wide patient blood management program：a retrospective observational study in four major adult tertiary-care hospitals［J］.Transfusion，2017，57（6）：1347-1358. ［30］National Blood Authority Australia.Patient Blood Management Guidelines［EB/OL］. （2011-2016）［2022-07-25］.https://www.blood.gov.au/pbm-guidelines. ［31］BOLCATO M，RUSSO M，RODRIGUEZ D，et al.Patient blood management implementation in light of new Italian laws on patient's safety［J］.Transfusion and Apheresis Science，2020，59（4）：102811. ［32］BOLCATO M，RUSSO M，TRENTINO K，et al.Patient blood management：the best approach to transfusion medicine risk management［J］.Transfusion and Apheresis Science，2020，59（4）：102779. ［33］ALTHOFF FC，NEB H，HERRMANN E，et al.Multimodal patient blood management program based on a three-pillar strategy：a systematic review and meta-analysis［J］.Annals of Surgery，2019，269（5）：794-804. ［34］VISAGIE M，QIN CX，CHO BC，et al.The impact of patient blood management on blood utilization and clinical outcomes in complex spine surgery［J］.Transfusion，2019，59（12）：3639-3645. ［35］KOTZ A，CARTER LA，SCALLY AJ.Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty：a quality improvement cycle［J］.British Journal of Anaesthesia，2012，108（6）：943-952. ［36］SHANDER A，VAN AKEN H，COLOMINA MJ，et al.Patient blood management in Europe［J］.Br J Anaesth，2012，109（1）：55-68. ［37］GOMBOTZ H，HOFMANN A，NORGAARD A，et al.Supporting patient blood management (PBM) in the EU-A practical implementation guide for hospitals［M］.Luxembourg：European Commission - Directorate-General for Health and Food Safety，2017：108. ［38］TOLEDO P.Shared decision-making and blood transfusions：is it time to Share More［J］.Anesth Analg，2014，118（6）：1151-1153. ［39］FRIEDMAN M，ARJA W，BATRA R，et al.Informed consent for blood transfusion：what do medicine residents tell? What do patients understand［J］.Am J Clin Pathol，2012，138（4）：559-565. ［40］STANWORTH SJ，NEW HV，APELSETH TO，et al.Effects of the COVID-19 pandemic on supply and use of blood for transfusion［J］.Lancet Haematol，2020，7（10）：e756-e764. ［41］GOOBIE SM，WARNE M.The essential role of patient blood management in a pandemic：a call for action［J］.Anesth Analg，2020， 131（1）：74-85. ［42］BARON DM，FRANCHINI M，GOOBIE SM，et al.Patient blood management during the COVID-19 pandemic：a narrative review［J］.Anaesthesia，2020，75（8）：1105-1113.［43］BOLCATO M，AURILIO MT，APRILE A，et al.Take-home messages from the COVID-19 pandemic: strengths and pitfalls of the italian national health service from a medico-legal point of view［J］.Healthcare（Basel,Switzerland），2020，9（1）：17. ［44］World Health Organization.Guidance on maintaining a safe and adequate blood supply during the coronavirus disease 2019 (COVID-19) pandemic and on the collection of COVID-19 convalescent plasma［EB/OL］.（2020-07-10）［2022-07-25］.https://apps.who.int/iris/bitstream/handle/10665/333182/WHO-2019-nCoV-BloodSupply-2020.2-eng.pdf?sequence=1&isAllowed=y.［45］中共中央 国务院.“健康中国2030”规划纲要［Z］.2016. ［46］健康中国行动推进委员会.健康中国行动（2019-2030年）［Z］.2019. ［47］国家卫生健康委员会，国家中医药管理局.公立医院高质量发展促进行动（2021-2025年）［Z］.2021. ［48］国务院.中国居民营养与慢性病状况报告（2020 年）［Z］.2020.

更新日期/Last Update: 2022-09-28